The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Daniel Eisner

Tel:
Work +1 212 335 4575
Email:
DLA Piper LLP (US)

Work Department

Corporate and Finance

Position

Partner and Co-Chair of DLA Piper's US Private Equity Practice

Career

Daniel Eisner concentrates on structuring and negotiating complex business transactions for private equity and other clients.

Among these transactions are domestic and international mergers, acquisitions, leveraged buyouts, recapitalizations, venture and growth capital investments, restructurings and workouts, debt and equity financings and formations of investment vehicles. Daniel regularly represents portfolio companies of private equity clients in acquisitions, financings, corporate governance and executive compensation.

Education

JD, Northwestern University School of Law; BA, The University of Chicago


United States: M&A/corporate and commercial

M&A: middle-market ($500m-999m)

Within: M&A: middle-market ($500m-999m)

DLA Piper LLP (US)’s corporate and securities group handles stock-for-stock mergers, management buyouts, tender offers, proxy contests, cross-border acquisitions, and divisional purchases and sales; it also represents special committees of boards and advises in hostile bids and proxy contests. In New York, Daniel Eisner led advice to Arsenal Capital Partners in the sale of its portfolio company Certara, known globally for model-informed drug development technology; and Marjorie Adams assisted Datatec, a South African ICT, with the sale of its North and Latin American businesses to US-based Synnex Corporation. Buy-side highlights included the team acting for CyrusOne in its acquisition of Sentinel Data Centers, a company that designs, builds, owns and operates turn-key and multi-tenant data center facilities for large enterprises; while in the large deal space, it assisted The Coca-Cola Company with its acquisition of a majority interest in Coca-Cola Beverages Africa from Anheuser-Busch InBev. The team also acted for Chicago-based private equity firm Wind Point Partners in its sale of plastic packaging manufacturer and distributor Novolex to The Carlyle Group; and assisted alternative investment firm Kayne Anderson Capital Advisors with its sale of Silver Hill Energy Partners and Silver Hill E&P II. Additional key advisers include New York-based US M&A chair Jonathan Klein; regional managing partner of the firm’s Texas offices and US corporate co-chair John Gilluly III, who advised Cheddar’s Casual Cafe on its sale to Darden Restaurants; managing partner of the San Diego offices Jeff Baglio, who ‘has strong negotiating skills’ and advises mature and emerging technology, life sciences and consumer products companies; and Silicon Valley- and San Francisco-based Eric Wang, who serves as co-chair of the Northern California corporate and finance practice.

[back to top]

Private equity buyouts

Within: Private equity buyouts

DLA Piper LLP (US) operates primarily in the middle market, with a high volume of transactions driven by the likes of ABRY Partners, Wind Point Partners, Arbor Investments, Prairie Capital, Sterling Partners and Stonebridge Partners. The firm has made a particular impression in the healthcare sector, marrying its strong private equity credentials with excellent healthcare regulatory expertise. Food and beverages, life sciences, chemicals and industrials are also key sectors. Moreover, the firm has made an impression in cross-border and multi-jurisdictional transactions for clients such as Wind Point and ABRY. It advised Wind Point on the sale of Novolex to Carlyle and represented Arbor in its acquisition of Greco & Sons. New York-based Daniel Eisner is an experienced figure, noted for his relationship with Arsenal Capital, and Atlanta’s Joe Alexander is the key relationship partner for ABRY. Miami partner Joshua Kaye is recommended for healthcare sector deals and is praised for his M&A and regulatory knowledge.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to